Continuous monitoring biosensors for advanced healthcare and environmental applications: challenges, material innovations and future directions
2673-5067
Abstract
This review critically discusses the development of continuous monitoring biosensors and the technological developments that have facilitated the transition from one-off or periodic measurement sensors to longer-term, connected and autonomous sensors. One hundred forty-four publications were analysed using a bibliometric approach, giving a map of the field that illustrates its growth, multidisciplinary aspects, technological development and key application areas. Electrochemical and optical transduction strategies are discussed in a systematic manner along with the advanced functional materials such as carbon nanotubes, graphene quantum dots, MXenes, covalent organic frameworks, molecularly imprinted polymers, functional polymers, hydrogels and chiral composites. Specific focus is placed on the use of these materials as an enhancement of charge transfer, analyte accessibility, selectivity, reversible recognition, antifouling behaviour, mechanical flexibility, signal stability and sensor regeneration. Architectures for wearable, implantable, biodegradable and self-powered are presented for continuous monitoring of clinically relevant biomarkers and metabolites, and platforms for environmental monitoring of waterborne pollutants, heavy metals and antibiotics, pathogens and other contaminants are explored. The review also examines the incorporation of microfluidics, wireless communication, artificial intelligence/machine learning, edge and cloud computing and Internet of Things technologies, which show the evolution towards multiplexed, connected and closed-loop biosensing systems. In all of these areas, analysis reveals that barriers to translation include sensor regeneration, biofouling, signal drift, matrix interference, calibration, energy requirements, biocompatibility, device integration, scalability, cybersecurity, regulatory compliance, and limited clinical/field validation. Notably, analytical parameters, including sensitivity and limit of detection, are demonstrated to be inadequate to assess deployment readiness, and long-term stability, matrix tolerance, reproducibility and real-world validation are all required. The areas identified for future direction include regenerative and antifouling sensing interfaces, multimodal and self-powered platforms, physiomimetic and minimally invasive architectures, AI-enabled signal interpretation, standardized performance metrics, scalable manufacturing, and rigorous clinical and environmental validation. In general, the review highlights advanced materials, biorecognition, device engineering, energy management, digital connectivity, and data analytics as the critical enabler for reliable continuous biosensing for personalized healthcare and environmental monitoring applications.